Phospho-NR4A1-S351 Antibody Blocking Peptide
€363.00
In stock
SKU
AC-BP3288a
Background:
NR4A1 is a member of the steroid-thyroid hormone-retinoid receptor superfamily. Expression is induced by phytohemagglutinin in human lymphocytes and by serum stimulation of arrested fibroblasts. The encoded protein acts as a nuclear transcription factor. Translocation of the protein from the nucleus to mitochondria induces apoptosis.
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP3288a was selected from the region of human Phospho-NR4A1-S351. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Other Accession: Q9Z239
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
NR4A1 is a member of the steroid-thyroid hormone-retinoid receptor superfamily. Expression is induced by phytohemagglutinin in human lymphocytes and by serum stimulation of arrested fibroblasts. The encoded protein acts as a nuclear transcription factor. Translocation of the protein from the nucleus to mitochondria induces apoptosis.
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP3288a was selected from the region of human Phospho-NR4A1-S351. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Other Accession: Q9Z239
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review